作者: Mei-Hwei Chang , Ding-Shinn Chen
DOI: 10.1016/S0168-7069(02)06072-X
关键词:
摘要: Publisher Summary This chapter discusses the prevention of hepatocellular carcinoma by hepatitis B immunization. Hepatitis virus (HBV) and C (HCV) are closely linked to development (HCC). HBV immunization has been successful in early studies preventing HBV-associated HCC. The provides a suggestion how future vaccines against HCV might prevent HCV-associated onset infection during childhood is an important factor leading chronicity sequelae, such as age at which occurs determining outcome infant. Neither antiviral therapy nor immune modulatory agents produce sustained response rates patients with chronic infection. Even those response, cannot be eradicated. Such treatments may not effectively HBV-related Many HCCs diagnosed late stage when HCC become inoperable unresponsive medical therapies. For these reasons, vaccination most effective way later